Magnolia decision a ‘rubric’ for PTAB petition success, USPTO's Squires says
By Nick Robertson ( May 15, 2026, 19:26 GMT | Insight) -- A new precedential Patent Trial and Appeal Board decision Thursday, Magnolia Medical Technologies v. Kurin, breaks little new ground but serves as a “rubric framework” for practitioners, laying out how the US Patent and Trademark Office weighs new considerations for discretionary denial of inter partes review, Director John Squires said Friday.US Patent and Trademark Office Director John Squires handed down a precedential decision late Thursday clearly laying out the factors he considers when determining whether to institute a petition for inter partes review at the Patent Trial and Appeal Board....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.